Department of Biomedical Informatics Archive — Page 13 of 25
-
October 20, 2021
VUMC’s Were, Sengstack, Stead honored by ACMI
Vanderbilt’s Martin Were, MD, MS, and Patricia Sengstack, DNP, RN-BC, have been elected to the American College of Medical Informatics (ACMI). William Stead, MD, has been named a Distinguished Fellows of ACMI. -
October 19, 2021
Artificial intelligence predicts opioid overdose in Tennessee
Researchers at Vanderbilt and the Tennessee Department of Health have developed 30-day predictive models for fatal and non-fatal opioid-related overdose among patients receiving opioid prescriptions in the state. -
September 30, 2021
AI predicts next-day delirium or coma in ICU patients
A team at Vanderbilt University Medical Center used machine learning to predict the likelihood of next-day brain function status changes in critical care patients. -
September 17, 2021
Grant creates center for maternal, pediatric precision therapeutics
Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics. -
September 16, 2021
Indiana University’s Embí named chair of the Department of Biomedical Informatics
Peter Embí, MD, MS, President and Chief Executive Officer for the Regenstrief Institute Inc., and professor of Medicine and Biostatistics & Health Data Science at the Indiana University School of Medicine, has been named as the new chair of Vanderbilt's Department of Biomedical Informatics. -
September 2, 2021
Study shows gene-drug interactions are common
When a drug or combination of drugs causes different responses in different people, genetic variation is often at play. Pharmacogenomics, through discovery of genetic risk and use of clinical genotyping, aims to reduce trial-and-error approaches to drug prescribing. -
August 12, 2021
Certain drug exposures correlate with reduced COVID severity: study
Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.